Literature DB >> 19305673

Turning 65 in Ontario: the impact of public drug benefit coverage on hospitalizations for acute and chronic disease.

Janet E Hux1, Alexander Kopp, Muhammad M Mamdani.   

Abstract

Ongoing access to medication is required for the management of many chronic diseases. We sought to examine the health impact of entering the provincial drug benefit plan at age 65 years. We constructed cohorts of same-aged individuals with incident heart failure, with diabetes and from the whole population using administrative data. The hazard of hospitalization at a given age compared to one year younger for ages 63 to 67 years was determined. On turning age 65, persons were more rather than less likely to be hospitalized for diabetes and acute infection when compared to the prior year. Among residents of low-income neighbourhoods these effects were no longer significant, but the risk of hospitalization for heart failure was increased. A similar effect was not observed for the paired cohorts at the transition from age 63 to 64 years. A health benefit of obtaining drug insurance was not observed in this study; however, the relationship may have been confounded by the effects of retirement and other changes occurring at age 65. Moreover, a benefit experienced by only a small proportion of the population may not be apparent in this analysis, which included many individuals unaffected by the policy.

Entities:  

Year:  2006        PMID: 19305673      PMCID: PMC2585341     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  33 in total

1.  Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions.

Authors:  J Elizabeth Jackson; Mark P Doescher; Barry G Saver; Paul Fishman
Journal:  Med Care       Date:  2004-11       Impact factor: 2.983

2.  The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.

Authors:  B C Martin; J A McMillan
Journal:  Med Care       Date:  1996-07       Impact factor: 2.983

3.  Variation in health and health care use by socioeconomic status in Winnipeg, Canada: does the system work well? Yes and no.

Authors:  N P Roos; C A Mustard
Journal:  Milbank Q       Date:  1997       Impact factor: 4.911

4.  On becoming 65 in Ontario. Effects of drug plan eligibility on use of prescription medicines.

Authors:  P V Grootendorst; B J O'Brien; G M Anderson
Journal:  Med Care       Date:  1997-04       Impact factor: 2.983

5.  The differential impact of copayment on drug use in a Medicaid population.

Authors:  C E Reeder; A A Nelson
Journal:  Inquiry       Date:  1985       Impact factor: 1.730

6.  Financial cost as an obstacle to hypertension therapy.

Authors:  N B Shulman; B Martinez; D Brogan; A A Carr; C G Miles
Journal:  Am J Public Health       Date:  1986-09       Impact factor: 9.308

7.  The effect of retirement on physical health.

Authors:  D J Ekerdt; L Baden; R Bossé; E Dibbs
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

8.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

9.  Pharmacy benefits and the use of drugs by the chronically ill.

Authors:  Dana P Goldman; Geoffrey F Joyce; Jose J Escarce; Jennifer E Pace; Matthew D Solomon; Marianne Laouri; Pamela B Landsman; Steven M Teutsch
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

10.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors:  R Garg; S Yusuf
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.